CompoAtlas

Nitric Oxide Booster

Natural health product licensed in Canada

Other names
NutraChamps Nitric Oxide Booster
Licence holder
NutraChamps Inc.
NPN or DIN-HM
80135647
Status
Active licence
Licence date
4 November 2024
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
L-Citrulline

Source : L-Citrulline malate

113.3 mgNot calculated
L-Arginine

Source : Monohydrochlorure de L-arginine

165.38 mgNot calculated

Non-medicinal ingredients

farine de riz, Hypromellose, Stéarate de magnésium, Silice

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years4 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

L-Arginine is (a non-essential amino acid) involved in protein synthesis. Source of (an) (non-essential) amino acid(s) involved in muscle protein synthesis. L-Arginine is a substrate for the synthesis of nitric oxide, a vasodilator, which helps support/maintain cardiovascular health. Source of/Provides antioxidants.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80135647

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line